Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

FDA Approves Entyvio for Ulcerative Colitis and Crohn's Disease

May 21, 2014

FDA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

Pfizer To Submit NDA to FDA for Palbociclib

May 21, 2014

Pfizer will submit a NDA with FDA for palbociclib, a treatment for locally advanced or metastatic breast cancer.

BMS and AbbVie Receive FDA Breakthrough Therapy Designation for Elotuzumab

May 21, 2014

BMS and AbbVie receive FDA breakthrough therapy designation for elotuzumab, an investigational humanized monoclonal antibody for multiple myeloma.

FDA Issues Complete Response Letter for Novartis' RLX030

May 20, 2014

FDA issues complete response letter for Novartis' RLX030 for acute heart failure.

Meissner Begins Operations At New Headquarters

May 20, 2014

Meissner moves into its new headquarters in Camarillo, California.

Novartis Settles Patent Litigation Over Gleevec

May 20, 2014

Novartis settles its litigation with the US subsidiary of Sun Pharma regarding Gleevec.

SGS Announces Appointments at New Facility in California

May 19, 2014

SGS makes two senior appointments at its new GMP/GLP laboratory in Carson, California.

Advanced Scientifics and Chemic Laboratories Announce Joint Cooperation Agreement

May 16, 2014

Advanced Scientifics and Chemic Laboratories enter a three-year joint cooperation agreement to collaborate on product development projects.

AstraZeneca and MRC Laboratory of Molecular Biology Launch Joint Research Fund

May 15, 2014

AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here